MDT BUE Week ended 31 Jul 2026

Weekly Investor Report

Medtronic plc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 33,660 ARS
1.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 2.5% above the Trend Line and sits at 44.5% of its 52-week range. The latest completed week returned 1.3%, after a 1.2% four-week move. The latest news-sentiment score is 54/100.

Setup score 50 out of 100
Latest Close 33,660 ARS 31 Jul 2026
1W Return 1.3% latest completed week
4W Return 1.2% short-term follow-through
12W Return 19.1% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Next-week expectancy is positive at 57.78% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.3% Latest completed week; four-week move 1.2%. Indicator stack 32/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.78% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 39 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 2.5% above the Trend Line and sits at 44.5% of its 52-week range. The latest completed week returned 1.3%, after a 1.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1212-week average 0.06

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.2% over four weeks, 19.1% over 12 weeks, and 10.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.3%
4W1.2%
12W19.1%
26W-12.8%
52W10.5%
Active trend streak0 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.78Latest activity-pressure read.
Pressure change586.8%Four-week change in activity pressure.
Leadership-20.12Latest relative-leadership reading.
RS change1.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 39 relevant articles.

13 positive · 23 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-18.9%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+11.5%Week of 5 Jun.
Worst week-7.0%Week of 8 May.
Latest week+1.3%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains8
Flat weeks0
Modest losses10
Sharp losses5
Recent vol4.9%13-week weekly-return volatility.
Base vol4.1%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryAR Medical Devices
4-week rank2 / 3
Group average2.2%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership

Four-week leaders

ABT · BUE10.6%MDT · BUE1.2%PHG · BUE-5.2%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape47/100

Trend, activity pressure, participation, and risk combine to a 47/100 tape read.

 Indicator analysis19/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.12; No reversal markers Next-Week ExpectancyPositive 57.78%

Next-week expectancy is positive with a 57.78% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 39 relevant articles.

Intuitive Surgical (ISRG) vs. Medtronic (MDT): Which MedTech Stock Looks Better Positioned for Growth? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202633,660 ARS1.3%32,851 ARS27,287 ARS0.78-20.127.7KOff
24 Jul 202633,220 ARS1.5%32,969 ARS27,150 ARS0.76-21.364.4KOff
17 Jul 202632,720 ARS0.1%33,088 ARS27,014 ARS0.62-20.935.3KOff
10 Jul 202632,680 ARS-1.7%33,276 ARS26,881 ARS0.46-23.384.8KOff
3 Jul 202633,260 ARS6.7%33,439 ARS26,747 ARS0.11-20.505.8KOff
26 Jun 202631,180 ARS-0.5%33,610 ARS26,606 ARS-0.18-24.04373Off
19 Jun 202631,326 ARS5.7%33,911 ARS26,478 ARS-0.44-27.85684Off
12 Jun 202629,624 ARS-3.1%34,144 ARS26,350 ARS-0.68-33.28262Off
5 Jun 202630,574 ARS11.5%34,349 ARS26,233 ARS-0.79-25.526.1KOff
29 May 202627,420 ARS-6.3%34,463 ARS26,104 ARS-0.99-35.1316.2KOff
22 May 202629,260 ARS3.2%34,692 ARS25,995 ARS-1.04-23.258.7KOff
15 May 202628,340 ARS0.3%34,938 ARS25,876 ARS-1.12-21.833.7KOff
8 May 202628,260 ARS-7.0%35,228 ARS25,765 ARS-1.14-23.833.7KOff
1 May 202630,400 ARS-2.6%35,470 ARS25,651 ARS-1.11-20.044.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.